• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 Next >
Johnson & Johnson Completes Acquisition of Ambrx
March 07, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 02, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
January 23, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
January 08, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
January 02, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 11, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 07, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
December 05, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
November 30, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Enterprise Business Review
November 16, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
October 23, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
October 19, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q3 2023 Results
October 17, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 18, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
August 30, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
August 23, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
August 21, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
August 16, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
July 24, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023
July 20, 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q2 2023 Results
July 20, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
July 10, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 06, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 10, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
May 03, 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap